Anticoagulation Reversal for ICH

June 24, 2019 00:26:09
Anticoagulation Reversal for ICH
Critical Care Perspectives in Emergency Medicine
Anticoagulation Reversal for ICH

Jun 24 2019 | 00:26:09

/

Show Notes

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits.  Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion.  In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

December 31, 2021 00:25:01
Episode Cover

The BOUGIE Trial

More than 1.5 million patients are intubated each year in the United States.  In up to 20% of patients, the first attempt at intubation...

Listen

Episode

September 25, 2018 00:24:02
Episode Cover

PARAMEDIC2 - Is Epi Useful in OHCA?

Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA.  PARAMEDIC2 was just published and is the largest randomized...

Listen

Episode 0

September 29, 2020 00:36:03
Episode Cover

Acute Liver Failure

Patients with acute liver failure can be incredibly sick and have an exceedingly high mortality.  Early identification and prompt, evidence-based management of the patient...

Listen